A. Moeini, D. Sia, N. Bardeesy, V. Mazzaferro, and J. M. Llovet, Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma, Clin Cancer Res, vol.22, issue.2, pp.291-300, 2016.

J. Bridgewater, P. R. Galle, S. A. Khan, J. M. Llovet, J. W. Park et al., Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma, J Hepatol, vol.60, issue.6, pp.1268-89, 2014.

B. Njei, Changing pattern of epidemiology in intrahepatic cholangiocarcinoma

, Hepatology, vol.60, issue.3, pp.1107-1115, 2014.

S. Rizvi and G. J. Gores, Pathogenesis, diagnosis, and management of cholangiocarcinoma

, Gastroenterology, vol.145, issue.6, pp.1215-1244, 2013.

S. Rizvi and G. J. Gores, Emerging molecular therapeutic targets for cholangiocarcinoma, J Hepatol, 2017.

M. L. Deoliveira, S. C. Cunningham, J. L. Cameron, F. Kamangar, J. M. Winter et al., Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution, Ann Surg, vol.245, issue.5, pp.755-62, 2007.

J. Valle, H. Wasan, D. H. Palmer, D. Cunningham, A. Anthoney et al.,

, Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer, N Engl J Med, vol.362, issue.14, pp.1273-81, 2010.

C. T. Gordon, T. Y. Tan, S. Benko, D. Fitzpatrick, S. Lyonnet et al., Long-range regulation at the SOX9 locus in development and disease, J Med Genet, vol.46, issue.10, pp.649-56, 2009.

J. Pritchett, V. Athwal, N. Roberts, N. A. Hanley, and K. P. Hanley, Understanding the role of SOX9 in acquired diseases: lessons from development, Trends Mol Med, vol.17, issue.3, pp.166-74, 2011.

A. Jo, S. Denduluri, B. Zhang, Z. Wang, L. Yin et al., The versatile functions of Sox9 in development, stem cells, and human diseases, Genes Dis, vol.1, issue.2, pp.149-61, 2014.

A. Antoniou, P. Raynaud, S. Cordi, Y. Zong, F. Tronche et al., Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9, Gastroenterology, vol.136, issue.7, pp.2325-2358, 2009.

K. Si-tayeb, F. P. Lemaigre, and S. A. Duncan, Organogenesis and development of the liver, Dev Cell, vol.18, issue.2, pp.175-89, 2010.

G. Carpino, V. Cardinale, P. Onori, A. Franchitto, P. B. Berloco et al., Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages, J Anat, vol.220, issue.2, pp.186-99, 2012.

Y. Kawaguchi, Sox9 and programming of liver and pancreatic progenitors, J Clin Invest, vol.123, issue.5, pp.1881-1887, 2013.

S. Jors, P. Jeliazkova, M. Ringelhan, J. Thalhammer, S. Durl et al., Lineage fate of ductular reactions in liver injury and carcinogenesis, J Clin Invest, vol.125, issue.6, pp.2445-57, 2015.

V. Cardinale, Y. Wang, G. Carpino, C. B. Cui, M. Gatto et al., Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets, Hepatology, vol.54, issue.6, pp.2159-72, 2011.

C. O. Leung, W. N. Mak, A. K. Kai, K. S. Chan, T. K. Lee et al., Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/beta-catenin signaling, Oncotarget, vol.7, issue.20, pp.29371-86, 2016.

C. Liu, L. Liu, X. Chen, J. Cheng, H. Zhang et al., Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma, Hepatology, vol.64, issue.1, pp.117-146, 2016.

H. Matsushima, T. Kuroki, A. Kitasato, T. Adachi, T. Tanaka et al., Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma, Dig Liver Dis, vol.47, issue.12, pp.1067-75, 2015.

H. L. Weng, Y. Liu, J. L. Chen, T. Huang, L. J. Xu et al., The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis, Hepatology, vol.50, issue.1, pp.230-273, 2009.

C. Meyer, Y. Liu, A. Kaul, I. Peipe, and S. Dooley, Caveolin-1 abrogates TGF-beta mediated hepatocyte apoptosis, Cell Death Dis, vol.4, p.466, 2013.

M. Dai, P. Wang, A. D. Boyd, G. Kostov, B. Athey et al., Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data, Nucleic Acids Res, vol.33, issue.20, p.175, 2005.

T. Otto and P. Sicinski, Cell cycle proteins as promising targets in cancer therapy, Nat Rev Cancer, vol.17, issue.2, pp.93-115, 2017.

T. Yamashita, J. J. Budhu, A. Forgues, M. , Y. W. Wang et al., EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features, Gastroenterology, vol.136, issue.3, pp.1012-1036, 2009.

E. Pastrana, V. Silva-vargas, and F. Doetsch, Eyes wide open: a critical review of sphereformation as an assay for stem cells, Cell Stem Cell, vol.8, issue.5, pp.486-98, 2011.

W. Chen, W. Zhao, L. Zhang, L. Wang, J. Wang et al., MALAT1-miR-101SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway, Oncotarget, vol.8, issue.55, pp.94317-94346, 2017.

C. Feng, F. Ma, C. Hu, J. A. Ma, J. Wang et al., SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell, Cell Cycle, vol.2017, pp.1-34

L. Garros-regulez, P. Aldaz, O. Arrizabalaga, V. Moncho-amor, and E. Carrasco-garcia,

L. Manterola, mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance, Expert Opin Ther Targets, vol.20, issue.4, pp.393-405, 2016.

Z. Liang, X. Bian, and H. Shim, Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer, Biochem Biophys Res Commun, vol.477, issue.3, pp.461-467, 2016.

C. Riemenschnitter, I. Teleki, V. Tischler, W. Guo, and Z. Varga, Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy, Springerplus, vol.2, p.695, 2013.

J. Wang, X. Xue, H. Hong, M. Qin, J. Zhou et al., Upregulation of microRNA524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9, Oncotarget, vol.8, issue.1, pp.574-82, 2017.

L. De-sousa-cavalcante and G. Monteiro, Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer, Eur J Pharmacol, vol.741, pp.8-16, 2014.

D. Wang and S. J. Lippard, Cellular processing of platinum anticancer drugs, Nat Rev Drug Discov, vol.4, issue.4, pp.307-327, 2005.